Remove market-access webinars
article thumbnail

Drug Channel Implications of the Inflation Reduction Act (NEW Live Video Webinar)

Drug Channels

Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s latest live video webinar: Drug Channel Implications of the Inflation Reduction Act This event will be broadcast live on Friday, April 5, 2024, from 12:00 p.m. This event is part of The Drug Channels 2024 Video Webinar Series.

article thumbnail

Immuno-oncology market set to grow in billions, but access concerns remain

Pharmaceutical Technology

The immuno-oncology market continues to evolve as treatments establish their presence across different types of cancer, having seen approvals in multiple indications in the past decade. Checkpoint modulators are forecasted to retain the largest share of this, based on the webinar. Market access was also a key point of focus.

Immunity 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

June 2023 Newsletter

Safe Biologics

REGISTER NOW: July 26th ASBM/GaBI Webinar on IRA Medicare Price Negotiation On July 26th, ASBM and the Generics and Biosimilars Initiative (GaBI) will host the first of two webinars examining the implications for patients and healthcare providers of the recently-passed Inflation Reduction Act (IRA). REGISTER for the webinar here.

article thumbnail

June 2023 Newsletter

Safe Biologics

REGISTER NOW: July 26th ASBM/GaBI Webinar on IRA Medicare Price Negotiation On July 26th, ASBM and the Generics and Biosimilars Initiative (GaBI) will host the first of two webinars examining the implications for patients and healthcare providers of the recently-passed Inflation Reduction Act (IRA). REGISTER for the webinar here.

article thumbnail

The Economics of Copay Accumulators, Maximizers, and Alternative Funding Programs (Video)

Drug Channels

In my most recent video webinar , I explored how plans and PBMs are turning to novel—and highly controversial—benefit design tools that access manufacturers’ patient support spending: copay accumulators, maximizers, and alternative funding programs.

78
article thumbnail

Webinar: Mastering Dealmaking Tools… to close deals faster and more efficiently

Fuld & Company Blog

Join our upcoming webinar with Fuld’s new strategic partner and the world’s fastest-growing dealmaking platform, Finalis, as we explore the strategies and tools essential for dealmakers to navigate the deal lifecycle with maximum efficiency and effectiveness.

52
article thumbnail

Copay Adjustment Programs: What Brand and Hub Teams Need to Know

Drug Channels

He explains how pharma brand teams and hub program managers can lessen the impact of accumulators and maximizers on patients’ access and adherence. Read on for Sam’s insights.

82